Steve Miller, Chief Operating Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 160,000 shares at $5.56 ($890K) on 2021-08-25, disclosed to the SEC on 2021-08-26.
Open-market sale of $890k CPRX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.56 | 80,000 | $445K | 50.0% |
| 2 | $5.56 | 80,000 | $445K | 50.0% |
| Total | $5.56 avg | 160,000 | $890K | 100% |
| Filing → |
| CPRX | SELL | 2024-08-22 | $4.1M | — | Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-11-23 | $1.6M | — | Filing → |